Jordan Gauthier, MD, MSc

Seattle Cancer Care Alliance
Assistant Professor, Division of Medical Oncology
University of Washington School of Medicine
UW Medicine
Assistant Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Medical Oncology
“I see every patient encounter as a precious opportunity to help, engage and learn.”
— Dr. Gauthier
Why do you practice hematology-oncology?

The meaningful connections I make with patients are part of what I enjoy about this specialty. One of my favorite memories is bonding with a patient who was undergoing a bone marrow transplant. He was a talented engineer and would show me pictures of all the amazing objects he built. He also taught me all about Japanese dog breeds and, I hope, I was able to teach him about the workings of the immune system. Not only did we develop an easy rapport, but we learned from each other, and I was grateful I could accompany him on his journey.

What’s it like to work with you?

I strive to be mindful of your life story beyond your disease, learning about your goals for care, your support system and what activities bring you joy. Depending on your interest and level of comfort, I like to share with you what’s going on beneath the surface of a symptom or disease process, discussing the biology of what’s happening so you know why you aren’t feeling well — or why you’re feeling better. As much as possible, I try to prepare you for what to expect during the treatment process so that you aren’t caught off guard by symptoms or side effects.

Provider background

Specialty: Medical Oncology

Blood cancers

I am a hematologist-oncologist who specializes in treating blood cancers such as leukemia and lymphoma. My expertise includes caring for patients receiving blood and bone marrow transplantation (BMT) as well as immunotherapies.

Much of my research so far has been focused on improving outcomes for patients treated with BMT or chimeric antigen receptor (CAR) T-cell therapy. This cellular immunotherapy engineers T cells (a type of immune cell) to attack tumors. Through my work, I have identified factors that can help predict the success of CAR T-cell therapy for patients who have leukemia and lymphoma. My background also includes international research collaborations through the European Society for Blood and Marrow Transplantation.

Diseases treated

Education, experience and certifications
Undergraduate Degree
University of Rennes, France
Medical Degree
University of Rennes, France
Henri Warembourg Faculty of Medicine, Lille, France
Immunotherapy Integrated Research Center
MSc, University of Lille, France
European Bone Marrow Transplantation Young Ambassador, 2017

This award recognizes talented scientists, physicians and nurses who are rising stars in the field of bone marrow transplantation.

Fred Hutchinson Cancer Research Center IIRC Fellowship Award

Dr. Gauthier was the first immunotherapy clinical fellow to serve in a joint Immunotherapy Integrated Research Center (IIRC) program in clinical and laboratory research.


Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
Complete title
Collection of Samples and Data from Patients Undergoing Treatment with Commercial Chimeric Antigen Receptor Engineered T-Cells
Study ID:
Complete title
Long-Term Follow-Up After Immune Effector Cell (IEC) Therapy
Study ID:
Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells
Complete title
Long-Term Follow-Up Protocol for Subjects Treated with Gene-Modified T Cells


Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.


SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.

Immunotherapy 101: What Patients Can Expect from CAR-T Cell Therapy

SCCA's Jordan Gauthier, MD, MSc, was interviewed by CURE about new National Comprehensive Cancer Network CAR-T therapy guidelines for patients.

Jordan Gauthier – About the NCCN Guidelines for Patients and the Side Effects of CAR T-therapy

SCCA’s Jordan Gauthier, MD, discussed recent NCCN Guidelines for Patients on CAR-T Therapy Side Effects with Onco’Zine.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.


SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.